As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/14/24  Bone Biologics Corp.              10-Q        3/31/24   55:3.9M                                   M2 Compliance LLC/FA     
 3/15/24  Bone Biologics Corp.              8-K:5       3/12/24   11:249K                                   M2 Compliance LLC/FA     
 3/14/24  Intracoastal Capital, LLC         SC 13G                 2:65K  Bone Biologics Corp.              EdgarAgents LLC/FA       
          Daniel B. Asher³
          Mitchell P. Kopin³
  3/6/24  Bone Biologics Corp.              8-K:1,8,9    3/4/24   17:1.1M                                   M2 Compliance LLC/FA     
  3/4/24‡ Bone Biologics Corp.              EFFECT       3/4/24    1:2K                                     SEC #5                   
  3/4/24  Bone Biologics Corp.              424B4                  1:353K                                   M2 Compliance LLC/FA     
  3/1/24  Bone Biologics Corp.              CORRESP¶     4/2/24    1:12K                                    M2 Compliance LLC/FA     
  3/1/24  Bone Biologics Corp.              8-K:8,9      3/1/24   12:265K                                   M2 Compliance LLC/FA     
 2/29/24  Bone Biologics Corp.              CORRESP¶     4/2/24    1:12K                                    M2 Compliance LLC/FA     
 2/28/24  Bone Biologics Corp.              CORRESP¶     4/2/24    1:13K                                    M2 Compliance LLC/FA     
 2/27/24  Bone Biologics Corp.              CORRESP¶     4/2/24    1:12K                                    M2 Compliance LLC/FA     
 2/26/24  Bone Biologics Corp.              S-1/A                  3:393K                                   M2 Compliance LLC/FA     
 2/23/24  Bone Biologics Corp.              S-1/A                  7:1.3M                                   M2 Compliance LLC/FA     
 2/21/24  Bone Biologics Corp.              10-K       12/31/23   63:6.3M                                   M2 Compliance LLC/FA     
 2/14/24‡ Ionic Ventures, LLC               SC 13G/A               1:70K  Bone Biologics Corp.              Genesis Filings LLC/FA   
          Brendan O’Neil³
          Ionic Management, LLC³
          Keith Coulston³
 2/14/24  Walleye Capital LLC               SC 13G/A               1:52K  Bone Biologics Corp.              Adviser Compliance … LLC 
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  Bone Biologics Corp.              Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
  2/5/24‡ SEC                               UPLOAD¶      4/2/24    2:39K  Bone Biologics Corp.                                       
 1/30/24  Bone Biologics Corp.              S-1                   64:9.1M                                   M2 Compliance LLC/FA     
 1/24/24‡ Bone Biologics Corp.              EFFECT      1/24/24    1:2K                                     SEC #5                   

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	424B4	Prospectus – Info Previously Omitted & New Facts or Events.
	CORRESP	Comment-Response or Other Letter to the SEC.
	EFFECT	SEC Notice of Effectiveness.
	S-1	Registration Statement (General Form) — Form S-1.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	UPLOAD	Comment or Other Letter from the SEC.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	¶	This Filing contains a delayed-release Document.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.